30 results
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
16 Oct 08
Entry into a Material Definitive Agreement
12:00am
to recall any Drug Product because such Drug Product may violate local, state or federal laws or regulations, the laws or regulations of any applicable … foreign government or agency or the Drug Product Specifications, or in the event that CLIENT elects to institute a voluntary recall, CLIENT shall
8-K
BPTH
Bio-Path Holdings Inc
19 Feb 08
Completion of Acquisition or Disposition of Assets
12:00am
liability claims or recall. Our business will expose us to potential product liability risks inherent in the clinical testing and manufacturing … and marketing of pharmaceutical products, and we may not be able to avoid significant product liability exposure. A product liability claim or recall could
10-K
2008 FY
BPTH
Bio-Path Holdings Inc
3 Apr 09
Annual report
12:00am
of future products, if any, will be harmed.
Exposure to product liability claims or recall. Our business will expose us to potential product liability … liability exposure. A product liability claim or recall could be detrimental to our business. In addition, we do not currently have any product
8-K
EX-1.1
BPTH
Bio-Path Holdings Inc
16 Jan 19
Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock
5:25pm
of, the testing of, the sale of, or the labeling and promotion of any Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure … or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert, post sale warning, “dear healthcare provider
424B3
fwrcsv5rn2
1 Apr 11
Prospectus supplement
12:00am
424B3
p6dr tdmls
30 Mar 12
Prospectus supplement
12:00am
8-K
EX-99.2
hb0n2d gr
9 Nov 22
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
6waq0h8 3fz2sg7xkg
21 Jan 14
Bio-Path Holdings, Inc. to Raise $10 Million in Registered Direct Offering
12:00am
8-K
EX-10.1
786pqjpjpiv2ef g3pwa
17 Feb 21
Placement Agency Agreement
5:11pm
8-K
EX-10.1
w6174tc7rj34v
22 Nov 19
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-10.1
o4e1lzny8i0w
13 Mar 19
Entry into a Material Definitive Agreement
4:24pm
8-K
EX-10.2
i1efn0zo pn7
7 Aug 23
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
4:42pm
8-K
EX-10.1
cuujsofemu5a
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm